Diethylcarbamazine in the treatment of patients with onchocerciasis.
作者信息
Awadzi K, Gilles H M
机构信息
Onchocerciasis Chemotherapy Research Centre, Hohoe Hospital, Ghana.
出版信息
Br J Clin Pharmacol. 1992 Oct;34(4):281-8. doi: 10.1111/j.1365-2125.1992.tb05632.x.
Abstract
摘要
相似文献
1
Diethylcarbamazine in the treatment of patients with onchocerciasis.
Br J Clin Pharmacol. 1992 Oct;34(4):281-8. doi: 10.1111/j.1365-2125.1992.tb05632.x.
2
Long-term treatment of onchocerciasis in children with low doses of diethylcarbamazine.
Ann Trop Med Parasitol. 1978 Feb;72(1):79-85. doi: 10.1080/00034983.1978.11719282.
3
Deseril and diethylcarbamazine in the treatment of onchocerciasis.
Trans R Soc Trop Med Hyg. 1976;70(5-6):534. doi: 10.1016/0035-9203(76)90151-6.
4
Onchocerciasis [proceedings].
Dermatologica. 1977;154(1):54-6.
5
Diethylcarbamazine lotion in onchocerciasis.
Lancet. 1980 May 3;1(8175):977-8. doi: 10.1016/s0140-6736(80)91420-8.
6
Letter: Collapse during treatment of onchocerciasis with diethylcarbamazine.
Trans R Soc Trop Med Hyg. 1974;68(1):72-3. doi: 10.1016/0035-9203(74)90259-4.
7
Onchocerciasis treated with diethylcarbamazine.
Br J Dermatol. 1977 Nov;97(5):551-4. doi: 10.1111/j.1365-2133.1977.tb14134.x.
8
DEC treatment of onchocerciasis.
Trop Doct. 1988 Apr;18(2):94.
9
Further studies on the treatment of ocular onchocerciasis with diethylcarbamazine and suramin.
Br J Ophthalmol. 1978 Jul;62(7):450-7. doi: 10.1136/bjo.62.7.450.
10
Topical diethylcarbamazine in ocular onchocerciasis.
Isr J Med Sci. 1972 Aug-Sep;8(8):1166-8.
引用本文的文献
1
Identification of a moxidectin dose for 4- to 11-year-old children to support registration and potential use for onchocerciasis elimination: results of an open-label pharmacokinetic and safety study.
Parasit Vectors. 2025 Jul 24;18(1):295. doi: 10.1186/s13071-025-06891-z.
2
An Overview on Antifilarial Efficacy of Heterocyclic Motifs Encompassing Synthetic Strategies, SAR and Commercialized Medications.
Curr Top Med Chem. 2025;25(11):1303-1350. doi: 10.2174/0115680266321838241024073444.
3
Onchocerca volvulus microfilariae in the anterior chambers of the eye and ocular adverse events after a single dose of 8 mg moxidectin or 150 µg/kg ivermectin: results of a randomized double-blind Phase 3 trial in the Democratic Republic of the Congo, Ghana and Liberia.
Parasit Vectors. 2024 Mar 15;17(1):137. doi: 10.1186/s13071-023-06087-3.
4
The pipeline for drugs for control and elimination of neglected tropical diseases: 2. Oral anti-infective drugs and drug combinations for off-label use.
Parasit Vectors. 2023 Oct 31;16(1):394. doi: 10.1186/s13071-023-05909-8.
5
Lymphatic Filariasis Elimination Status: Infections in Human Populations after Five Effective Rounds of Mass Drug Administration in Zambia.
Trop Med Infect Dis. 2023 Jun 22;8(7):333. doi: 10.3390/tropicalmed8070333.
6
Bma-LAD-2, an Intestinal Cell Adhesion Protein, as a Potential Therapeutic Target for Lymphatic Filariasis.
mBio. 2022 Jun 28;13(3):e0374221. doi: 10.1128/mbio.03742-21. Epub 2022 Apr 27.
7
Onchocerciasis drug development: from preclinical models to humans.
Parasitol Res. 2021 Dec;120(12):3939-3964. doi: 10.1007/s00436-021-07307-4. Epub 2021 Oct 13.
8
Intestinal UDP-glucuronosyltransferase as a potential target for the treatment and prevention of lymphatic filariasis.
PLoS Negl Trop Dis. 2019 Sep 12;13(9):e0007687. doi: 10.1371/journal.pntd.0007687. eCollection 2019 Sep.
9
Efficacy and safety of co-administered ivermectin plus albendazole for treating soil-transmitted helminths: A systematic review, meta-analysis and individual patient data analysis.
PLoS Negl Trop Dis. 2018 Apr 27;12(4):e0006458. doi: 10.1371/journal.pntd.0006458. eCollection 2018 Apr.
10
Potential Value of Triple Drug Therapy with Ivermectin, Diethylcarbamazine, and Albendazole (IDA) to Accelerate Elimination of Lymphatic Filariasis and Onchocerciasis in Africa.
PLoS Negl Trop Dis. 2017 Jan 5;11(1):e0005163. doi: 10.1371/journal.pntd.0005163. eCollection 2017 Jan.
本文引用的文献
1
A histological study of onchocerciasis treated with hetrazan.
Br Med J. 1952 May 10;1(4766):992-4. doi: 10.1136/bmj.1.4766.992.
2
Observations on the use of hetrazan in onchocerciasis in Mexico.
Am J Trop Med Hyg. 1951 Sep;31(5):628-32. doi: 10.4269/ajtmh.1951.s1-31.628.
3
[CLINICAL STUDY OF THE ACTION OF METHYSERGIDE ON THERAPEUTIC SHOCK DUE TO DIETHYLCARBAMAZINE IN ONCHOCERCIASIS (PRELIMINARY TRIAL)].
Bull Soc Pathol Exot Filiales. 1964 May-Jul;57:528-36.
4
5
Cortisone and prednisone in the suppression of allergic reactions to diethylcarbamazine treatment of onchocerciasis.
Am J Trop Med Hyg. 1957 May;6(3):546-52. doi: 10.4269/ajtmh.1957.6.546.
6
The reappearance, rate of increase and distribution of the microfilariae of Onchocerca volvulus following treatment with diethylcarbamazine.
Trans R Soc Trop Med Hyg. 1957 Jan;51(1):37-44. doi: 10.1016/0035-9203(57)90004-4.
7
Diethylcarbamazine in the treatment of onchocerciasis.
Trans R Soc Trop Med Hyg. 1953 Jan;47(1):66-9. doi: 10.1016/0035-9203(53)90025-x.
8
[Effect of hetrazan on Onchocerca volvulus in adult stage].
Medicina (Mex). 1952 Nov 25;32(664):521-3.
9
Changes in visual function and in the posterior segment of the eye during treatment of onchocerciasis with diethylcarbamazine citrate.
Br J Ophthalmol. 1980 Mar;64(3):191-200. doi: 10.1136/bjo.64.3.191.
10
The effect of variations in urinary pH on the pharmacokinetics of diethylcarbamazine.
Br J Clin Pharmacol. 1981 Dec;12(6):807-12. doi: 10.1111/j.1365-2125.1981.tb01311.x.
Zotero 插件